• info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) +1-214-377-1121 (US)
  • Sign In
  • Register

OtherGlobal Hospital Acquired Infections (HAI) Diagnostics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • RnM2414264
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 103 pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections.

Scope of the Report:

This report studies the Hospital Acquired Infections (HAI) Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hospital Acquired Infections (HAI) Diagnostics market by product type and applications/end industries.

The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric population base. Advancing age of the geriatric population makes them more vulnerable and prone to diseases, thus increasing the demand for diagnosis.

The global Hospital Acquired Infections (HAI) Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hospital Acquired Infections (HAI) Diagnostics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

BioMérieux

Abbott Laboratories

Roche AG

Siemens Healthcare

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Molecular Diagnostics Tests

Other In-vitro Diagnostic Tests

Market Segment by Applications, can be divided into

Bloodstream Infections (BSI)

Urinary Tract Infections (UTI)

Surgical Site Infections (SSI)

Pneumonia

Others


Table of Contents

1 Hospital Acquired Infections (HAI) Diagnostics Market Overview

1.1 Product Overview and Scope of Hospital Acquired Infections (HAI) Diagnostics

1.2 Classification of Hospital Acquired Infections (HAI) Diagnostics by Types

1.2.1 Global Hospital Acquired Infections (HAI) Diagnostics Revenue Comparison by Types (2017-2023)

1.2.2 Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Types in 2017

1.2.3 Molecular Diagnostics Tests

1.2.4 Other In-vitro Diagnostic Tests

1.3 Global Hospital Acquired Infections (HAI) Diagnostics Market by Application

1.3.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Bloodstream Infections (BSI)

1.3.3 Urinary Tract Infections (UTI)

1.3.4 Surgical Site Infections (SSI)

1.3.5 Pneumonia

1.3.6 Others

1.4 Global Hospital Acquired Infections (HAI) Diagnostics Market by Regions

1.4.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Hospital Acquired Infections (HAI) Diagnostics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Hospital Acquired Infections (HAI) Diagnostics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hospital Acquired Infections (HAI) Diagnostics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Hospital Acquired Infections (HAI) Diagnostics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hospital Acquired Infections (HAI) Diagnostics Status and Prospect (2013-2023)

1.5 Global Market Size of Hospital Acquired Infections (HAI) Diagnostics (2013-2023)

2 Manufacturers Profiles

2.1 BioMérieux

2.1.1 Business Overview

2.1.2 Hospital Acquired Infections (HAI) Diagnostics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 BioMérieux Hospital Acquired Infections (HAI) Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Abbott Laboratories

2.2.1 Business Overview

2.2.2 Hospital Acquired Infections (HAI) Diagnostics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.3 Roche AG

2.3.1 Business Overview

2.3.2 Hospital Acquired Infections (HAI) Diagnostics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

2.4 Siemens Healthcare

2.4.1 Business Overview

2.4.2 Hospital Acquired Infections (HAI) Diagnostics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Hospital Acquired Infections (HAI) Diagnostics Market Competition, by Players

3.1 Global Hospital Acquired Infections (HAI) Diagnostics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Hospital Acquired Infections (HAI) Diagnostics Players Market Share

3.2.2 Top 10 Hospital Acquired Infections (HAI) Diagnostics Players Market Share

3.3 Market Competition Trend

4 Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Regions

4.1 Global Hospital Acquired Infections (HAI) Diagnostics Revenue and Market Share by Regions

4.2 North America Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

4.3 Europe Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

4.5 South America Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

5 North America Hospital Acquired Infections (HAI) Diagnostics Revenue by Countries

5.1 North America Hospital Acquired Infections (HAI) Diagnostics Revenue by Countries (2013-2018)

5.2 USA Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

5.3 Canada Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

5.4 Mexico Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

6 Europe Hospital Acquired Infections (HAI) Diagnostics Revenue by Countries

6.1 Europe Hospital Acquired Infections (HAI) Diagnostics Revenue by Countries (2013-2018)

6.2 Germany Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

6.3 UK Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

6.4 France Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

6.5 Russia Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

6.6 Italy Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue by Countries

7.1 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue by Countries (2013-2018)

7.2 China Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

7.3 Japan Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

7.4 Korea Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

7.5 India Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

8 South America Hospital Acquired Infections (HAI) Diagnostics Revenue by Countries

8.1 South America Hospital Acquired Infections (HAI) Diagnostics Revenue by Countries (2013-2018)

8.2 Brazil Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

8.3 Argentina Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

8.4 Colombia Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Hospital Acquired Infections (HAI) Diagnostics by Countries

9.1 Middle East and Africa Hospital Acquired Infections (HAI) Diagnostics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

9.3 UAE Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

9.4 Egypt Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

9.6 South Africa Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2013-2018)

10 Global Hospital Acquired Infections (HAI) Diagnostics Market Segment by Type

10.1 Global Hospital Acquired Infections (HAI) Diagnostics Revenue and Market Share by Type (2013-2018)

10.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Forecast by Type (2018-2023)

10.3 Molecular Diagnostics Tests Revenue Growth Rate (2013-2023)

10.4 Other In-vitro Diagnostic Tests Revenue Growth Rate (2013-2023)

11 Global Hospital Acquired Infections (HAI) Diagnostics Market Segment by Application

11.1 Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Application (2013-2018)

11.2 Hospital Acquired Infections (HAI) Diagnostics Market Forecast by Application (2018-2023)

11.3 Bloodstream Infections (BSI) Revenue Growth (2013-2018)

11.4 Urinary Tract Infections (UTI) Revenue Growth (2013-2018)

11.5 Surgical Site Infections (SSI) Revenue Growth (2013-2018)

11.6 Pneumonia Revenue Growth (2013-2018)

11.7 Others Revenue Growth (2013-2018)

12 Global Hospital Acquired Infections (HAI) Diagnostics Market Size Forecast (2018-2023)

12.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size Forecast (2018-2023)

12.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Forecast by Regions (2018-2023)

12.3 North America Hospital Acquired Infections (HAI) Diagnostics Revenue Market Forecast (2018-2023)

12.4 Europe Hospital Acquired Infections (HAI) Diagnostics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue Market Forecast (2018-2023)

12.6 South America Hospital Acquired Infections (HAI) Diagnostics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Hospital Acquired Infections (HAI) Diagnostics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Hospital Acquired Infections (HAI) Diagnostics . Industry analysis & Market Report on Hospital Acquired Infections (HAI) Diagnostics is a syndicated market report, published as Global Hospital Acquired Infections (HAI) Diagnostics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Hospital Acquired Infections (HAI) Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,480.00
$5,220.00
$6,960.00
2,336.82
3,505.23
4,673.64
3,202.30
4,803.44
6,404.59
421,567.20
632,350.80
843,134.40
230,770.63
346,155.95
461,541.26
Add To Cart Credit card Logo

Related Reports


Reason to Buy